Retail infant formula is a supermarket purchase. The specialist formulas — extensively hydrolysed, amino acid-based, lactose-free where clinically indicated, high-calorie — are NHS prescriptions and they arrive in community pharmacy from GPs, paediatricians and allergy services. Community pharmacy teams handle them routinely, but the rules governing indication, supply and substitution are more specific than first-line infant nutrition usually requires.
The ACBS gate
Specialist infant formulas are listed by the Advisory Committee on Borderline Substances (ACBS) within the BNF for Children. Each product carries a specific set of approved indications. A prescription endorsed "ACBS" signals that the prescriber is prescribing within those indications. A prescription without endorsement can still be dispensed but the underlying indication should sit within the ACBS criteria for the product.
The most commonly encountered ACBS-listed infant formulas in the community fall into four groups.
Extensively hydrolysed formulas (EHF). First-line for non-IgE-mediated cows' milk protein allergy (CMPA) per NICE NG193. Product examples include Aptamil Pepti 1/2, SMA Althéra, Similac Alimentum, Nutramigen LGG. They are protein-hydrolysate based; the protein fragments are small enough to avoid triggering most reactions. They smell and taste different from routine infant formula. Parents are often taken aback by this — counsel clearly.
Amino acid-based formulas (AAF). Second-line for CMPA where EHF is not tolerated, or first-line for severe IgE-mediated CMPA, faltering growth, or multiple food allergies. Examples: Neocate LCP, SMA Alfamino, Nutramigen PURAMINO. Cost is higher; prescribing is usually allergy-service or paediatrician-initiated.
Lactose-free formulas. Indicated for confirmed lactose intolerance (uncommon in infants), some post-gastroenteritis recovery, and congenital lactase deficiency (rare). Examples: SMA LF, Aptamil Lactose-Free. A routine parental concern about "wind" is not a lactose intolerance diagnosis, and lactose-free formula is not a substitute for EHF in CMPA.
High-energy formulas. Used for faltering growth. Infatrini and Similac High Energy are common. Prescribed by community paediatrics, dietetics or hospital teams.
Anti-reflux formulas (Enfamil AR, Aptamil Anti-Reflux, SMA Anti-Reflux) are not ACBS-listed and are available for retail purchase. Prescribing is uncommon.
The typical prescribing pathway
For non-IgE-mediated CMPA the pathway in NICE NG193 is: GP or health visitor recognises symptoms (reflux, eczema, blood in stool, colic), trials a two to four week EHF challenge under paediatric or community dietitian oversight, confirms improvement, then continues EHF until a structured home reintroduction (milk ladder) around 9 to 12 months. Amino acid formula is reserved for EHF non-response, severe disease or multiple allergies.
Substitution rules in community pharmacy
Specialist infant formulas are not generic-substitutable. Protein hydrolysis patterns and amino acid profiles differ between products. An infant established on Althéra cannot be swapped to Pepti 1 without clinical reassessment. If a prescription is for a specific product and the pharmacy cannot source it, the appropriate action is to contact the prescriber — not to substitute.
Specialist formulas are frequently short on wholesaler stock. Practical tips:
- Check major wholesalers first (AAH, Phoenix, Alliance Healthcare).
- Some products are distributor-restricted — Nutricia, Abbott and Reckitt's hydrolysate products occasionally flow through direct accounts.
- Branded generics (SMA vs Aptamil vs Similac) are not equivalent — do not substitute.
- If supply fails, an emergency supply to a named patient is rarely appropriate; refer prescriber for an alternative prescription.
Quantities and prescribing
Typical prescribing is 800 g to 900 g per day of made-up feed for a 0-6 month infant, less for older infants moving onto solids. Prescribers usually specify a 4-week quantity. Pharmacies should calculate against the infant's age rather than assuming a fixed tin count — underprovisioning leaves a parent short; overprovisioning wastes drug tariff spend.
Red flags
| Signal | Action |
|---|---|
| Parent asks to "try" EHF without prescription | Signpost GP assessment — CMPA needs diagnosis, not product experimentation |
| Prescription for AAF in an infant with no specialist involvement | Gentle query — AAF is usually specialist-initiated |
| Recurring short-quantity prescriptions for faltering-growth formula | Suggest nominated supply arrangement with dietetics |
| Parent seeking routine infant formula on prescription | Not ACBS-eligible; retail purchase |
Broader sector context
Infant nutrition prescribing is a small but steady share of community pharmacy dispensing. PharmSee data show that community pharmacy workforce remains under sustained pressure — 1,651 live pharmacy vacancies across eleven public sources on 14 April 2026, with 290 at a single hiring chain. Specialist-formula queries are one of the richer consultation moments available at the counter; they reward the time.
Caveats
Specific formulations and ACBS listings change. Always work from the current BNF for Children and the ACBS approved indications as printed. Product availability shifts monthly.
Sources
- NICE NG193: Cows' milk protein allergy in children.
- BNF for Children, specialist infant formula section.
- ACBS approved indications list.